跳至主要内容
临床试验/NCT00795938
NCT00795938已完成1 期

An Open-Label, Crossover Study In Healthy Volunteers To Evaluate The Pharmacokinetics Of Sildenafil Following Administration Of An Experimental Tablet Of Sildenafil With Or Without Water Relative To Viagra® Conventional Oral Tablet With Water.

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2008年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
18
试验地点
1
主要终点
Blood levels of sildenafil

研究概览

简要总结

This study to will compare the blood levels of sildenafil following administration of an experimental tablet vs. the conventional oral tablet.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy males between the ages of 18 and 55 years. Body Mass Index of 18 to 30 kg/m2, and a total body weight >50 kg (110 lbs).

排除标准

  • Smoking in excess of the equivalent of 5 cigarettes per day. Treatment with an experimental drug within 30 days or sildenafil, vardenafil, tadalfil within 4 days before first study dose.
  • Develop blood pressure lowering or experience dizziness, lightheadedness when going from the laying down position to standing position.

研究组 & 干预措施

Conventional Oral Tablet With Water

Active Comparator

干预措施: Sildenafil (Drug)

Experimental Tablet With Water

Experimental

干预措施: Sildenafil (Drug)

Experimental Tablet Without Water

Experimental

干预措施: Sildenafil (Drug)

结局指标

主要结局

Blood levels of sildenafil

时间窗: 1 day

次要结局

  • Safety(1 day)
  • Blood levels of a metabolite of sildenafil(1 day)

研究者

发起方
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Study to Compare the Blood Levels of Sildenafil... | 临床试验